Surgical Sealant And Adhesives Market: Market Size & Forecast 2026

Surgical sealants and adhesives are medical devices designed to stop bleeding (hemostasis), seal tissues, and close wounds during surgical procedures. They are broadly classified into synthetic and biologically derived products, including fibrin sealants, cyanoacrylate-based adhesives, polyethylene glycol (PEG) gels, and collagen-based compounds. The market is measured by multiple independent research providers, as government statistical agencies do not publish dedicated market data for this segment.

• •Estimated at approximately $2.79 billion globally in 2025, with projections ranging from $4.05 billion to $7.5 billion by the early 2030s depending on methodology.
• •Growth rates reported by market intelligence firms range from roughly 6% to 11% CAGR, reflecting differences in product scope and geographic coverage.
• •The broader medical adhesives and sealants industry, which includes wound closure applications, is valued at over $15 billion, making surgical products a significant subsegment.

The volume of surgical procedures performed globally continues to rise, fueled by aging demographics and the growing prevalence of chronic diseases requiring surgical intervention. Minimally invasive surgical techniques, which often require effective tissue sealing, are expanding across specialties including cardiovascular, orthopedic, and general surgery. Regulatory approvals for new product formulations and combinations, such as sealants paired with hemostatic agents, have broadened clinical adoption.

• •Aging populations and rising incidence of conditions such as cardiovascular disease, cancer, and diabetes are increasing the number of surgical interventions performed globally.
• •Minimally invasive and robotic-assisted surgeries create demand for products that can achieve hemostasis and wound closure in confined surgical spaces.
• •Product innovation, including synthetic sealants with faster polymerization and biologics offering improved biocompatibility, continues to drive surgeon preference and procedural adoption.

The market is segmented by product type, primarily sealants, hemostats, and tissue adhesives, and by application area, including cardiovascular, general surgery, orthopedic, and wound closure. Geographically, North America commands the largest share, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement frameworks. The Asia-Pacific region is expected to register the fastest growth rate, driven by improving access to surgical care and expanding hospital capacity in China and India.

• •The U.S. surgical sealants and adhesives market alone was valued at approximately $810 million in 2023 and is projected to continue expanding through 2030.
• •North America holds a dominant position, while Asia-Pacific is expected to be the fastest-growing region due to rising healthcare expenditure and increasing surgical adoption.
• •Key application areas include cardiovascular surgery, general and laparoscopic surgery, trauma, and wound management.

What are the recent trends and outlook?

The market outlook remains positive through the early 2030s, with continued expansion expected as surgical volumes rise globally and healthcare systems adopt more cost-effective wound management solutions. Integration of sealants with other hemostatic products into single-platform offerings is an emerging trend. Regulatory pathways and reimbursement policies will remain critical factors in shaping adoption rates across different healthcare markets.

• •Dual-function products that combine hemostasis and tissue sealing in a single formulation are gaining clinical traction.
• •Regulatory approval timelines and healthcare reimbursement policies will significantly influence product adoption and pricing dynamics across regions.
• •With independent research estimates placing the market at $4-7.5 billion by the early 2030s, the sector is positioned for sustained growth beyond the current decade.